ES2574825T3 - Análogos de glicolípidos útiles como inmunoadyuvantes - Google Patents

Análogos de glicolípidos útiles como inmunoadyuvantes Download PDF

Info

Publication number
ES2574825T3
ES2574825T3 ES08848559.4T ES08848559T ES2574825T3 ES 2574825 T3 ES2574825 T3 ES 2574825T3 ES 08848559 T ES08848559 T ES 08848559T ES 2574825 T3 ES2574825 T3 ES 2574825T3
Authority
ES
Spain
Prior art keywords
group
groups
compound
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08848559.4T
Other languages
English (en)
Spanish (es)
Inventor
Luigi Panza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2574825T3 publication Critical patent/ES2574825T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
ES08848559.4T 2007-10-12 2008-10-10 Análogos de glicolípidos útiles como inmunoadyuvantes Active ES2574825T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97978507P 2007-10-12 2007-10-12
US979785P 2007-10-12
PCT/IB2008/003263 WO2009060305A2 (en) 2007-10-12 2008-10-10 Analogues of glycolipids useful as immunoadjuvants

Publications (1)

Publication Number Publication Date
ES2574825T3 true ES2574825T3 (es) 2016-06-22

Family

ID=40626266

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08848559.4T Active ES2574825T3 (es) 2007-10-12 2008-10-10 Análogos de glicolípidos útiles como inmunoadyuvantes

Country Status (8)

Country Link
US (1) US8697659B2 (cg-RX-API-DMAC10.html)
EP (1) EP2483287B1 (cg-RX-API-DMAC10.html)
JP (1) JP5416125B2 (cg-RX-API-DMAC10.html)
CN (1) CN102066394B (cg-RX-API-DMAC10.html)
AU (1) AU2008326138B2 (cg-RX-API-DMAC10.html)
CA (1) CA2702344C (cg-RX-API-DMAC10.html)
ES (1) ES2574825T3 (cg-RX-API-DMAC10.html)
WO (1) WO2009060305A2 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2471518B1 (en) 2009-05-18 2017-08-23 Sigmoid Pharma Limited Composition comprising oil drops
EP2464341B1 (en) * 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
KR101675657B1 (ko) * 2012-03-19 2016-11-11 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. 탄수화물-당지질 컨쥬게이트 백신
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
WO2016071515A1 (en) 2014-11-07 2016-05-12 Sigmoid Pharma Limited Compositions comprising cyclosporin
WO2022256467A1 (en) * 2021-06-02 2022-12-08 The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health Compositions and methods comprising deoxy-pentitols

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW261533B (cg-RX-API-DMAC10.html) * 1992-07-16 1995-11-01 Kirin Brewery
AU2002327097B2 (en) * 2001-08-16 2007-05-24 Japan As Represented By President Of National Centre Of Neurology And Psychiatry Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
GB0314682D0 (en) 2003-06-24 2003-07-30 Isis Innovation Materials and methods relating to the modulation of T cell response to soluble antigen
AU2005280163B2 (en) * 2004-08-27 2011-11-24 Albert Einstein College Of Medicine, Inc. Ceramide derivatives as modulators of immunity and autoimmunity
US7923013B2 (en) * 2004-12-28 2011-04-12 The Rockefeller University Glycolipids and analogues thereof as antigens for NKT cells
EP1776963A1 (en) * 2005-10-19 2007-04-25 Gbf-Gesellschaft Für Biotechnologische Forschung Mbh Hexosylceramides as adjuvants and their uses in pharmaceutical compositions

Also Published As

Publication number Publication date
JP5416125B2 (ja) 2014-02-12
AU2008326138A1 (en) 2009-05-14
AU2008326138B2 (en) 2013-10-17
CA2702344C (en) 2016-09-27
CN102066394B (zh) 2015-04-01
US20110033485A1 (en) 2011-02-10
WO2009060305A2 (en) 2009-05-14
EP2483287B1 (en) 2016-03-16
JP2011510910A (ja) 2011-04-07
WO2009060305A3 (en) 2013-05-23
EP2483287A2 (en) 2012-08-08
CN102066394A (zh) 2011-05-18
US8697659B2 (en) 2014-04-15
CA2702344A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
JP7412840B2 (ja) 治療薬の送達のための組成物及び方法
TWI899203B (zh) 脂質奈米粒子組成物
AU2005280163B2 (en) Ceramide derivatives as modulators of immunity and autoimmunity
EP3077006B1 (en) Polymer-carbohydrate conjugates for drug delivery technology
TW202229227A (zh) 脂質化合物及脂質奈米顆粒組合物
CN114040918B (zh) 皂苷缀合物及含其的疫苗或药物组合物
US8697659B2 (en) Analogues of glycolipids useful as immunoadjuvants
KR20230041744A (ko) 화학식 -nh-cx-a 또는 -nh-cx-nh-a의 적어도 하나의 말단 라디칼을 포함하는 지질 화합물, 이를 포함하는 조성물 및 이의 용도
EP2231196B1 (en) Increase of immune response by peptide antigen linkage
JP2011510910A5 (cg-RX-API-DMAC10.html)
TW202027786A (zh) 包含抗原肽- 佐劑核苷酸結合物之免疫誘導劑及包含其之醫藥組成物
BRPI0820960B1 (pt) composição, composição farmacêutica, e uso da composição
KR20230039713A (ko) 절단성 지질 화합물, 이를 함유하는 조성물, 및 이의 용도
Li et al. Efficient synthesis of α-galactosylceramide and its C-6 modified analogs
CN114126419A (zh) 基于皂苷的疫苗佐剂
Romerio Synthesis and biological characterization of TLR4 agonists as innovative vaccine adjuvants
AU2013202865B2 (en) Increase of immune response and targeting by antigens and/or drug linkage
HK40064797A (en) Saponin conjugate and vaccine or pharmaceutical composition comprising the same
BRPI0711235A2 (pt) composto, composição farmacêutica, método para induzir seletivamente uma resposta imune tipo th-1 em um mamìfero, método para tratar uma doença que requer uma resposta tipo th-1, método para aumentar a imunogenicidade para um antìgeno em um mamìfero e método para preparar um composto